MoneyWorks4Me

Parenteral Drugs India informs about quarterly statement on investor complaints

15 Jul 2016 Evaluate

Parenteral Drugs India has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1777.10
Dr. Reddys Labs. 1195.25
Cipla 1331.25
Lupin 2011.20
Zydus Lifesciences 1151.40
View more..